Literature DB >> 25730761

Development of a cerebrospinal fluid lateral reservoir model in rhesus monkeys (Macaca mulatta).

Cynthia M Lester McCully1, John Bacher2, Rhonda P MacAllister3, Emilie A Steffen-Smith3, Kadharbatcha Saleem4, Marvin L Thomas2, Rafael Cruz3, Katherine E Warren3.   

Abstract

Rapid, serial, and humane collection of cerebrospinal fluid (CSF) in nonhuman primates (NHP) is an essential element of numerous research studies and is currently accomplished via two different models. The CSF reservoir model (FR) combines a catheter in the 4th ventricle with a flexible silastic reservoir to permit circulating CSF flow. The CSF lateral port model (LP) consists of a lateral ventricular catheter and an IV port that provides static access to CSF and volume restrictions on sample collection. The FR model is associated with an intensive, prolonged recovery and frequent postsurgical hydrocephalus and nonpatency, whereas the LP model is associated with an easier recovery. To maximize the advantages of both systems, we developed the CSF lateral reservoir model (LR), which combines the beneficial features of the 2 previous models but avoids their limitations by using a reservoir for circulating CSF flow combined with catheter placement in the lateral ventricle. Nine adult male rhesus monkeys were utilized in this study. Pre-surgical MRI was performed to determine the coordinates of the lateral ventricle and location of choroid plexus (CP). The coordinates were determined to avoid the CP and major blood vessels. The predetermined coordinates were 100% accurate, according to MRI validation. The LR system functioned successfully in 67% of cases for 221 d, and 44% remain functional at 426 to 510 d postoperatively. Compared with established models, our LR model markedly reduced postoperative complications and recovery time. Development of the LR model was successful in rhesus macaques and is a useful alternative to the FR and LP methods of CSF collection from nonhuman primates.

Entities:  

Mesh:

Year:  2015        PMID: 25730761      PMCID: PMC4396933     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  3 in total

1.  A functional observational battery in non-human primates for regulatory-required neurobehavioral assessments.

Authors:  David V Gauvin; Theodore J Baird
Journal:  J Pharmacol Toxicol Methods       Date:  2008-05-25       Impact factor: 1.950

2.  A rhesus monkey model for continuous infusion of drugs into cerebrospinal fluid.

Authors:  C L McCully; F M Balis; J Bacher; J Phillips; D G Poplack
Journal:  Lab Anim Sci       Date:  1990-09

3.  Primate model for long-term study of intraventricularly or intrathecally administered drugs and intracranial pressure.

Authors:  J H Wood; D G Poplack; W A Bleyer; A K Ommaya
Journal:  Science       Date:  1977-02-04       Impact factor: 47.728

  3 in total
  7 in total

1.  Improved CNS exposure to tocilizumab after cerebrospinal fluid compared to intravenous administration in rhesus macaques.

Authors:  Anandani Nellan; Cynthia M Lester McCully; Rafael Cruz Garcia; Nalini Jayaprakash; Brigitte C Widemann; Daniel W Lee; Katherine E Warren
Journal:  Blood       Date:  2018-06-28       Impact factor: 22.113

2.  Minimally Invasive Lumbar Port System for the Collection of Cerebrospinal Fluid from Rhesus Macaques (Macaca mulatta).

Authors:  Rhonda Pung MacAllister; Cynthia M Lester McCully; John Bacher; Marvin L Thomas; Rafael Cruz; Solomon Wangari; Katherine E Warren
Journal:  Comp Med       Date:  2016       Impact factor: 0.982

3.  Chronic Collection of Cerebrospinal Fluid from Rhesus Macaques (Macaca mulatta) with Cisterna Magna Ports: Update on Refinements.

Authors:  David B Gilberto; Maria S Michener; Brad E Smith; Peter J Szczerba; Marie A Holahan; Tasha L Gray; Sherri L Motzel
Journal:  Comp Med       Date:  2021-12-13       Impact factor: 1.565

4.  Flow Rate and Apparent Volume of Cerebrospinal Fluid in Rhesus Macaques (Macaca mulatta) Based on the Pharmacokinetics of Intrathecally Administered Inulin.

Authors:  Cynthia M Lester McCully; Louis T Rodgers; Rafael Cruz Garica; Marvin L Thomas; Cody J Peer; William D Figg; Dennis E Barnard; Katherine E Warren
Journal:  Comp Med       Date:  2020-10-12       Impact factor: 0.982

5.  Characterizing the pharmacokinetics of panobinostat in a non-human primate model for the treatment of diffuse intrinsic pontine glioma.

Authors:  Louis T Rodgers; Cynthia M Lester McCully; Arman Odabas; Rafael Cruz; Cody J Peer; William D Figg; Katherine E Warren
Journal:  Cancer Chemother Pharmacol       Date:  2020-01-01       Impact factor: 3.333

6.  Plasma and cerebrospinal fluid pharmacokinetics of the DNA methyltransferase inhibitor, 5-azacytidine, alone and with inulin, in nonhuman primate models.

Authors:  Cynthia Lester McCully; Louis T Rodgers; Rafael Cruz; Marvin L Thomas; Cody J Peer; William D Figg; Katherine E Warren
Journal:  Neurooncol Adv       Date:  2020-01-01

7.  Pharmacokinetics of the disialoganglioside, GD2, a circulating tumor biomarker for neuroblastoma, in nonhuman primates.

Authors:  Frank M Balis; Cynthia Lester McCully; Christine M Busch; Elizabeth Fox; Katherine E Warren
Journal:  J Circ Biomark       Date:  2021-12-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.